These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25613071)

  • 1. A novel tumor suppressor gene in basal cell carcinoma: inhibition of growth factor-2.
    Temel M; Turkmen A; Dokuyucu R; Cevik C; Oztuzcu S; Cengiz B; Mutaf M
    Tumour Biol; 2015 Jun; 36(6):4611-6. PubMed ID: 25613071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.
    Ythier D; Brambilla E; Binet R; Nissou D; Vesin A; de Fraipont F; Moro-Sibilot D; Lantuejoul S; Brambilla C; Gazzeri S; Pedeux R
    Lung Cancer; 2010 Aug; 69(2):180-6. PubMed ID: 19962781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.
    Borkosky SS; Gunduz M; Nagatsuka H; Beder LB; Gunduz E; Ali MA; Rodriguez AP; Cilek MZ; Tominaga S; Yamanaka N; Shimizu K; Nagai N
    J Cancer Res Clin Oncol; 2009 May; 135(5):703-13. PubMed ID: 18998165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosome 4q32-35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genes.
    Sironi E; Cerri A; Tomasini D; Sirchia SM; Porta G; Rossella F; Grati FR; Simoni G
    J Cutan Pathol; 2004 Apr; 31(4):318-22. PubMed ID: 15005689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.
    Pan YQ; Zhang X; Xu DP; Bao WG; Lin AF; Xu HH; Yan WH
    Neoplasma; 2014; 61(4):468-75. PubMed ID: 24712846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma.
    Zhang HK; Pan K; Wang H; Weng DS; Song HF; Zhou J; Huang W; Li JJ; Chen MS; Xia JC
    Cancer Lett; 2008 Mar; 261(2):183-92. PubMed ID: 18160212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
    Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
    Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
    Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
    Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear ING2 expression is reduced in osteosarcoma.
    Han XR; Bai XZ; Sun Y; Yang Y
    Oncol Rep; 2014 Nov; 32(5):1967-72. PubMed ID: 25190103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression levels of the sirtuins in patients with BCC.
    Temel M; Koç MN; Ulutaş S; Göğebakan B
    Tumour Biol; 2016 May; 37(5):6429-35. PubMed ID: 26631040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of basal cell carcinoma: analysis of differential gene expression by differential display PCR and expression array.
    Welss T; Papoutsaki M; Michel G; Reifenberger J; Chimenti S; Ruzicka T; Abts HF
    Int J Cancer; 2003 Mar; 104(1):66-72. PubMed ID: 12532421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of EGFR overexpression on the recurrence of basal cell carcinomas with positive surgical margins.
    Biray Avci C; Kaya I; Ozturk A; Ozates Ay NP; Sezgin B; Kurt CC; Akyildiz NS; Bozan A; Yaman B; Akalin T; Apaydin F
    Gene; 2019 Mar; 687():35-38. PubMed ID: 30419251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 gene expression in basal cell carcinoma.
    Eshkoor SA; Ismail P; Rahman SA; Oshkour SA
    Arch Med Res; 2008 Oct; 39(7):668-73. PubMed ID: 18760195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-noncoding RNAs in basal cell carcinoma.
    Sand M; Bechara FG; Sand D; Gambichler T; Hahn SA; Bromba M; Stockfleth E; Hessam S
    Tumour Biol; 2016 Aug; 37(8):10595-608. PubMed ID: 26861560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signatures linked with aggressive behavior in basal cell carcinoma: a report of 6 cases.
    Fernandes H; Fernandes N; Bhattacharya S; Chen W; Seth A; Hameed M; Mirani N; Lambert WC
    Am J Dermatopathol; 2010 Aug; 32(6):550-6. PubMed ID: 20489570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of loss of heterozygosity on chromosome region 9p21-p22 but lack of p16INK4a/p19ARF mutations in greek patients with basal cell carcinoma of the skin.
    Saridaki Z; Koumantaki E; Liloglou T; Sourvinos G; Papadopoulos O; Zoras O; Spandidos DA
    J Invest Dermatol; 2000 Oct; 115(4):719-25. PubMed ID: 10998150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES.
    Aoki M; Pawankar R; Niimi Y; Kawana S
    Int Arch Allergy Immunol; 2003 Mar; 130(3):216-23. PubMed ID: 12660426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.
    Omland SH; Wettergren EE; Mollerup S; Asplund M; Mourier T; Hansen AJ; Gniadecki R
    BMC Cancer; 2017 Oct; 17(1):675. PubMed ID: 28987144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.